리서치사:Market Glass, Inc. (Formerly Global Industry Analysts, Inc.)
발행일:2024년 11월
페이지 정보:영문 92 Pages
라이선스 & 가격 (부가세 별도)
한글목차
세계의 비타민 D 요법 시장은 2030년까지 86억 달러에 도달
2023년에 40억 달러로 추정되는 세계의 비타민 D 요법 시장은 분석 기간인 2023-2030년에 CAGR 11.5%로 성장하며, 2030년에는 86억 달러에 달할 것으로 예측됩니다. 본 리포트에서 분석한 부문의 하나인 경구투여는 CAGR 11.9%를 기록하며, 분석 기간 종료시에는 59억 달러에 달할 것으로 예측됩니다. 비경구투여 부문의 성장률은 분석 기간 중 CAGR 10.8%로 추정됩니다.
미국 시장은 11억 달러로 추정, 중국은 CAGR 10.8%로 성장 예측
미국의 비타민 D 요법 시장은 2023년에 11억 달러로 추정됩니다. 세계 2위의 경제대국인 중국은 2030년까지 13억 달러의 시장 규모에 달할 것으로 예측되며, 분석 기간인 2023-2030년의 CAGR은 10.8%입니다. 기타 주목해야 할 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간 중 CAGR은 각각 10.0%와 9.6%로 예측됩니다. 유럽에서는 독일이 CAGR 8.3%로 성장할 것으로 예측됩니다.
세계의 비타민 D 요법 시장 - 주요 동향과 촉진요인 정리
비타민 D 요법이란 무엇이며, 왜 현대 헬스케어에서 중요한가?
비타민 D 요법이란 비타민 D 결핍증 및 관련 건강 상태를 예방하고 치료하기 위해 비타민D 보충제 및 의약품을 의료용으로 사용하는 것을 말합니다. 비타민D는 칼슘 흡수, 뼈 건강, 면역 기능, 골다공증, 구루병, 심혈관 질환, 자가면역 질환 등 다양한 질병을 예방하는 데 중요한 역할을 하는 중요한 영양소입니다. 비타민D 요법에는 시중에서 판매되는 보충제, 처방용 비타민D(비타민 D2, D3 등), 고용량 주사제 등이 있으며, 비타민D 농도가 낮거나 결핍 위험이 있는 사람, 만성 신장질환, 골다공증, 흡수 장애 증후군 등 특정 질환을 앓고 있는 환자들에게 자주 처방됩니다.
비타민 D 요법의 중요성은 전 세계에서 수백만 명이 앓고 있는 비타민D 결핍증에 대처하는 능력에 있습니다. 비타민D 결핍증은 뼈 약화, 골절 위험 증가, 면역 기능 저하 및 기타 건강 문제를 유발할 수 있습니다. 비타민D 요법은 뼈 건강, 면역 지원, 염증 조절에 필수적인 역할을 하므로 골다공증과 같은 증상을 관리하고, 노인의 낙상 위험을 줄이고, 전반적인 건강 상태를 개선하는 데 필수적입니다. 비타민D가 호흡기 감염의 중증도를 낮추고 정신건강을 지원하는 등 보다 광범위한 효과가 있다는 연구 결과가 속속 밝혀지면서 비타민D 요법은 예방과 치료 모두에서 헬스케어 전략의 핵심이 되고 있습니다.
기술의 발전은 어떻게 비타민 D 요법 시장을 형성하고 있는가?
기술의 발전은 비타민 D 요법의 효과, 정확성, 접근성을 크게 향상시켜 헬스케어 분야 전반의 혁신을 촉진하고 있습니다. 주요 발전 중 하나는 리포좀 비타민D, 나노 에멀전, 혀 밑 스프레이와 같은 보다 생체 이용률이 높은 제제의 등장입니다. 이러한 첨단 전달 시스템은 비타민 D의 생체 이용률을 높이고 소화 시스템을 우회하여 혈류에 직접 흡수되도록하여 흡수 변동을 줄입니다. 이는 흡수 장애가 있거나 결핍을 빠르게 개선해야 하는 환자에게 특히 유용합니다.
비타민D 농도 진단 검사의 발전도 시장 형성에 중요한 역할을 하고 있습니다. 고급 면역 분석 및 질량 분석기를 포함한 고정밀 검사 방법은 혈청 25-하이드록시 비타민 D 농도를 정확하게 측정할 수 있으며, 의료 서비스 프로바이더가 개인의 필요에 따라 맞춤 치료를 할 수 있습니다. 신속한 현장 검사를 통해 임상의는 비타민D 결핍을 보다 효과적으로 선별하고 비타민D 용량을 조정할 수 있게 되어 개인별 맞춤 치료 계획을 지원할 수 있게 되었습니다. 모바일 앱과 웨어러블 기기 등 디지털 건강 기술은 비타민D 섭취량, 햇볕 노출 및 전반적인 건강 결과를 추적할 수 있는 기능을 제공함으로써 환자들이 치료와 순응도를 보다 효과적으로 모니터링할 수 있게 되었습니다.
비타민D 요법과 원격의료의 통합은 특히 원격지나 의료 서비스가 부족한 지역에서 비타민D 요법에 대한 접근성을 더욱 확대했습니다. 원격의료 플랫폼을 통해 의료 서비스 프로바이더는 가상 진찰을 통해 결핍을 진단하고, 보충제를 처방하고, 환자를 추적 관찰할 수 있으며, 더 많은 사람들이 비타민D 요법을 이용할 수 있게 되었습니다. 또한 AI 기반 건강 분석은 환자의 인구 통계, 식습관, 지역적 위치, 생활습관 요인에 따라 비타민D 결핍을 예측하여 예방적 개입과 보다 타깃팅된 치료를 돕고 있습니다. 이러한 기술 혁신은 비타민 D 요법의 기능을 확장할 뿐만 아니라 현대 의료 시스템에서 맞춤형 의료, 디지털 헬스케어, 예방 의료와 같은 광범위한 동향과도 부합합니다.
다양한 건강 상태에 대한 비타민D 요법의 새로운 적용 사례는?
비타민D 요법은 뼈 건강, 면역 기능 및 전반적인 건강 상태를 지원하는 중요한 역할을 하므로 다양한 건강 상태에 대한 적용이 확대되고 있습니다. 골다공증과 뼈 헬스케어에서 비타민D 요법은 칼슘 흡수를 개선하고 골밀도를 높이며 골절 위험을 줄이기 위해 특히 노인과 폐경 후 여성에게 사용되는 표준 치료법입니다. 뼈 건강을 최적화하고 골감소증이 골다공증으로 진행되는 것을 예방하기 위해 칼슘 보충제나 비스포스포네이트와 같은 약물과 병용하는 경우가 많습니다.
비타민D 요법은 면역 건강 측면에서 면역 반응을 향상시키고 감염 위험을 감소시킬 수 있는 것으로 알려져 있습니다. 충분한 비타민D가 독감 및 기타 바이러스성 질환을 포함한 호흡기 감염 위험을 낮출 수 있다는 연구 결과가 있으며, COVID-19 팬데믹 기간 중 비타민D가 질병의 심각성을 줄이고 면역 회복력을 지원하는 잠재적 역할에 대한 관심이 높아졌습니다. 면역력 강화 요법의 일환으로 비타민D 보충제 사용이 증가했습니다.
당뇨병, 심혈관 질환, 자가면역 질환과 같은 만성질환에서 비타민D 요법은 전반적인 건강을 지원하고 질병의 진행을 관리하는 데 사용됩니다. 연구에 따르면 비타민D 결핍은 인슐린 저항성, 고혈압, 다발성 경화증과 같은 자가면역 질환의 위험 증가와 관련이 있는 것으로 나타났습니다. 만성콩팥병(CKD) 환자의 경우, 비타민D 요법은 미네랄과 뼈 장애를 관리하고 이차성 부갑상선기능항진증을 치료하며 신장 골다공증과 같은 합병증을 예방하는 데 도움이 됩니다. 정신건강 분야에서는 비타민D 요법이 우울증 증상 완화, 인지 기능 지원, 노인의 치매 위험 감소에 도움이 될 수 있는 것으로 보고되고 있습니다. 이처럼 비타민D 요법은 다양한 건강 상태에 적용되고 있으며, 예방적 건강관리, 만성질환 관리, 면역력 강화에 중요한 역할을 하고 있습니다.
비타민 D 요법 시장의 성장 원동력은?
비타민 D 요법 시장의 성장은 비타민D 결핍에 대한 인식 증가, 골다공증 및 만성질환의 유병률 증가, 비타민D의 광범위한 건강 효과에 대한 연구 발전 등 여러 가지 요인에 의해 주도되고 있습니다. 이러한 결핍증의 확산은 선별검사, 예방적 보충제 섭취, 치료적 개입 증가로 이어져 시판용 및 처방전용 비타민D 제품에 대한 수요를 견인하고 있습니다.
특히 노년층의 골다공증 유병률 증가로 인해 비타민D 요법에 대한 수요가 더욱 증가하고 있습니다. 전 세계에서 노인 인구가 증가함에 따라 비타민D 보충을 포함한 효과적인 뼈 헬스케어 전략의 필요성이 더욱 절실해지고 있습니다. 뼈 건강에 대한 인식을 높이고 일상적인 비타민D 섭취를 장려하는 공중보건 노력도 시장 성장에 기여하고 있습니다. 골다공증, 골감소증, 골절 예방을 위한 표준 치료 프로토콜에 비타민D 요법을 포함시킴으로써 비타민D는 노인 헬스케어의 핵심 요소로 자리 잡았습니다.
연구의 발전으로 비타민D는 면역 기능 지원, 염증 억제, 특정 암 및 자가면역 질환의 위험 감소 등 다양한 건강상의 이점이 있는 것으로 밝혀지고 있습니다. 이러한 증거들이 쌓이면서 비타민D는 예방적 보충제로서 소비자들의 관심이 높아졌고, 헬스케어와 소매 채널 모두에서 비타민D에 대한 수요가 증가하고 있습니다. 개인화된 영양 섭취 동향도 시장 성장에 기여하고 있으며, 영유아, 임산부, 운동선수, 노인과 같은 특정 계층을 위한 비타민D 보충제 수요가 더욱 증가하고 있습니다.
생물학적 제제, 개인 맞춤형 치료 접근법, 디지털 헬스 통합과 같은 기술 혁신이 진행되면서 비타민 D 요법 시장은 강력한 성장세를 보이고 있습니다. 이러한 추세는 일반 대중의 인식 제고, 예방의학에 대한 관심 증가, 의료비 지출 증가와 함께 비타민D 요법을 다양한 사람들의 전반적인 건강 결과를 개선하는 데 초점을 맞춘 현대 의료 전략의 필수적인 요소로 만들고 있습니다.
Global Vitamin D Therapy Market to Reach US$8.6 Billion by 2030
The global market for Vitamin D Therapy estimated at US$4.0 Billion in the year 2023, is expected to reach US$8.6 Billion by 2030, growing at a CAGR of 11.5% over the analysis period 2023-2030. Oral Administration, one of the segments analyzed in the report, is expected to record a 11.9% CAGR and reach US$5.9 Billion by the end of the analysis period. Growth in the Parenteral Administration segment is estimated at 10.8% CAGR over the analysis period.
The U.S. Market is Estimated at US$1.1 Billion While China is Forecast to Grow at 10.8% CAGR
The Vitamin D Therapy market in the U.S. is estimated at US$1.1 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$1.3 Billion by the year 2030 trailing a CAGR of 10.8% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 10.0% and 9.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 8.3% CAGR.
Global Vitamin D Therapy Market - Key Trends & Drivers Summarized
What Is Vitamin D Therapy, and Why Is It So Crucial in Modern Healthcare?
Vitamin D Therapy refers to the medical use of vitamin D supplements or medications to prevent or treat vitamin D deficiency and related health conditions. Vitamin D is a vital nutrient that plays a critical role in calcium absorption, bone health, immune function, and the prevention of various diseases, including osteoporosis, rickets, cardiovascular diseases, and autoimmune disorders. Vitamin D therapy can involve over-the-counter supplements, prescription-grade vitamin D (like vitamin D2 or D3), or high-dose injections, and it is commonly prescribed for individuals with low vitamin D levels, those at risk of deficiency, or patients with specific conditions like chronic kidney disease, osteoporosis, or malabsorption syndromes.
The importance of vitamin D therapy lies in its ability to address widespread vitamin D deficiency, which affects millions globally and can lead to weakened bones, increased risk of fractures, impaired immune function, and other health issues. Given its essential role in bone health, immune support, and inflammation control, vitamin D therapy is crucial in managing conditions like osteoporosis, reducing the risk of falls in the elderly, and supporting overall health. As research continues to reveal broader benefits of vitamin D, such as its potential role in reducing the severity of respiratory infections and supporting mental well-being, vitamin D therapy has become a cornerstone of both preventive and therapeutic healthcare strategies.
How Are Technological Advancements Shaping the Vitamin D Therapy Market?
Technological advancements have significantly enhanced the effectiveness, precision, and accessibility of Vitamin D Therapy, driving innovation across healthcare sectors. One of the major developments is the rise of more bioavailable formulations, such as liposomal vitamin D, nanoemulsions, and sublingual sprays, which improve absorption rates and increase the effectiveness of supplementation. These advanced delivery systems enhance the bioavailability of vitamin D, allowing it to be absorbed directly into the bloodstream, bypassing the digestive system and reducing variability in absorption. This is particularly beneficial for patients with malabsorption disorders or those requiring rapid correction of deficiency.
Advancements in diagnostic testing for vitamin D levels have also played a critical role in shaping the market. High-precision testing methods, including advanced immunoassays and mass spectrometry, provide accurate measurements of serum 25-hydroxyvitamin D levels, allowing healthcare providers to tailor therapy to individual needs. Rapid point-of-care testing has made it easier for clinicians to screen for deficiencies and adjust vitamin D dosages more effectively, supporting personalized treatment plans. Digital health technologies, such as mobile apps and wearable devices, now offer features for tracking vitamin D intake, sun exposure, and overall health outcomes, enabling patients to monitor their therapy and compliance more effectively.
The integration of vitamin D therapy with telemedicine has further expanded access, especially in remote or underserved areas. Telehealth platforms enable healthcare providers to diagnose deficiencies, prescribe supplements, and monitor patient progress through virtual consultations, making vitamin D therapy more accessible to a broader population. Additionally, AI-driven health analytics are being used to predict vitamin D deficiencies based on patient demographics, dietary habits, geographic location, and lifestyle factors, supporting proactive intervention and more targeted therapy. These technological innovations not only expand the capabilities of vitamin D therapy but also align with broader trends toward personalized medicine, digital healthcare, and preventive care in modern healthcare systems.
What Are the Emerging Applications of Vitamin D Therapy Across Different Health Conditions?
Vitamin D Therapy is finding expanding applications across a variety of health conditions, driven by its essential role in supporting bone health, immune function, and overall well-being. In osteoporosis and bone health management, vitamin D therapy is a standard treatment used to improve calcium absorption, enhance bone mineral density, and reduce the risk of fractures, particularly in the elderly and postmenopausal women. It is often used in combination with calcium supplements and medications like bisphosphonates to optimize bone health and prevent osteopenia from progressing to osteoporosis.
In immune health, vitamin D therapy is recognized for its potential to enhance immune responses and reduce the risk of infections. Studies have shown that adequate vitamin D levels can help lower the risk of respiratory infections, including the flu and other viral illnesses. During the COVID-19 pandemic, there was significant interest in the potential role of vitamin D in reducing disease severity and supporting immune resilience, prompting increased use of vitamin D supplements as part of immune-boosting regimens.
In chronic conditions like diabetes, cardiovascular disease, and autoimmune disorders, vitamin D therapy is used to support overall health and manage disease progression. Research indicates that vitamin D deficiency is associated with increased risks of insulin resistance, hypertension, and autoimmune diseases like multiple sclerosis. For patients with chronic kidney disease (CKD), vitamin D therapy helps manage mineral and bone disorders, addressing secondary hyperparathyroidism and preventing complications like renal osteodystrophy. In mental health, vitamin D therapy has shown promise in alleviating symptoms of depression, supporting cognitive function, and reducing the risk of dementia in older adults. The expanding applications of vitamin D therapy across these diverse health conditions highlight its critical role in preventive healthcare, chronic disease management, and immune support.
What Drives Growth in the Vitamin D Therapy Market?
The growth in the Vitamin D Therapy market is driven by several factors, including increasing awareness of vitamin D deficiency, rising prevalence of osteoporosis and chronic diseases, and growing research into the broader health benefits of vitamin D. One of the primary growth drivers is the high global prevalence of vitamin D deficiency, which affects people across all age groups, geographic locations, and socioeconomic statuses. This widespread deficiency has led to increased screening efforts, preventive supplementation, and therapeutic interventions, driving demand for both over-the-counter and prescription-grade vitamin D products.
The rising prevalence of osteoporosis, particularly among the aging population, has further fueled demand for vitamin D therapy. As the global elderly population continues to grow, the need for effective bone health management strategies, including vitamin D supplementation, has become more urgent. Public health initiatives promoting bone health awareness and encouraging routine vitamin D intake have also contributed to market growth. The integration of vitamin D therapy into standard treatment protocols for osteoporosis, osteopenia, and fracture prevention has made it a central component of geriatric healthcare.
Advancements in research have revealed additional health benefits of vitamin D, such as its potential to support immune function, reduce inflammation, and lower the risk of certain cancers and autoimmune diseases. This expanding body of evidence has increased consumer interest in vitamin D as a preventive health supplement, boosting demand in both healthcare and retail channels. The growing trend toward personalized nutrition has also contributed to market growth, with tailored vitamin D supplements designed for specific demographics, such as infants, pregnant women, athletes, and the elderly, further driving demand.
With ongoing innovations in bioavailable formulations, personalized treatment approaches, and digital health integration, the vitamin D therapy market is poised for robust growth. These trends, combined with increasing public awareness, preventive health initiatives, and rising healthcare spending, make vitamin D therapy a vital component of modern healthcare strategies focused on improving overall health outcomes across diverse populations.
SCOPE OF STUDY:
The report analyzes the Vitamin D Therapy market in terms of US$ Million by the following Application; Method; Route of Administration, and Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.
Select Competitors (Total 36 Featured) -
Abbott
Alkem Laboratories Ltd.
Cadila Healthcare Ltd.
GlaxoSmithKline PLC
Merck & Co., Inc.
Novartis AG
Pfizer Inc
Sanofi
Sun Pharmaceutical Industries Ltd.
Torrent Pharmaceuticals Ltd.
TABLE OF CONTENTS
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Global Economic Update
Vitamin D Therapy - Global Key Competitors Percentage Market Share in 2024 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Rising Prevalence of Vitamin D Deficiency Drives Demand for Vitamin D Therapy
Expanding Use in Bone Health Supplements Sets the Stage for Market Growth
Case Overview: Demand for Vitamin D in Immune Health Enhances Market
Innovations in Vitamin D Fortified Foods Generate New Opportunities
Focus on Preventive Healthcare Boosts Adoption of Vitamin D Therapy
Growing Use in Osteoporosis Treatment Sustains Vitamin D Therapy Demand
Push for Pediatric Supplementation Drives Vitamin D Therapy Market
Increasing Adoption in Elderly Nutrition Enhances Vitamin D Demand
Expanding Application in Cardiovascular Health Drives Market Growth
Case Overview: Demand for Vitamin D in Prenatal Care Propels Market
Focus on Oral and Injectable Forms of Vitamin D Therapy Bodes Well for Growth
Increasing Use in Skin Health Products Drives Vitamin D Therapy Market
Expanding Application in Chronic Disease Management Propels Demand
Regulatory Push for Vitamin D Fortification Enhances Market Opportunities
Focus on Vitamin D Testing Increases Awareness and Boosts Market Demand
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Recent Past, Current & Future Analysis for Vitamin D Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 2: World Historic Review for Vitamin D Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 3: World 16-Year Perspective for Vitamin D Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
TABLE 4: World Recent Past, Current & Future Analysis for Osteoporosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 5: World Historic Review for Osteoporosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 6: World 16-Year Perspective for Osteoporosis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 7: World Recent Past, Current & Future Analysis for Rickets by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 8: World Historic Review for Rickets by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 9: World 16-Year Perspective for Rickets by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 10: World Recent Past, Current & Future Analysis for Muscle Weakness by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 11: World Historic Review for Muscle Weakness by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 12: World 16-Year Perspective for Muscle Weakness by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 13: World Recent Past, Current & Future Analysis for Autoimmune Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 14: World Historic Review for Autoimmune Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 15: World 16-Year Perspective for Autoimmune Disorders by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 16: World Recent Past, Current & Future Analysis for Skin Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 17: World Historic Review for Skin Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 18: World 16-Year Perspective for Skin Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 19: World Recent Past, Current & Future Analysis for Prescription Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 20: World Historic Review for Prescription Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 21: World 16-Year Perspective for Prescription Drugs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 22: World Recent Past, Current & Future Analysis for OTC Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 23: World Historic Review for OTC Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 24: World 16-Year Perspective for OTC Drugs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 25: World Vitamin D Therapy Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
TABLE 26: World Recent Past, Current & Future Analysis for Oral by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 27: World Historic Review for Oral by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 28: World 16-Year Perspective for Oral by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 29: World Recent Past, Current & Future Analysis for Parenteral by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 30: World Historic Review for Parenteral by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 31: World 16-Year Perspective for Parenteral by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 32: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 33: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 34: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
III. MARKET ANALYSIS
UNITED STATES
Vitamin D Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
TABLE 35: USA Recent Past, Current & Future Analysis for Vitamin D Therapy by Route Of Administration - Oral and Parenteral - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 36: USA Historic Review for Vitamin D Therapy by Route Of Administration - Oral and Parenteral Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 37: USA 16-Year Perspective for Vitamin D Therapy by Route Of Administration - Percentage Breakdown of Value Sales for Oral and Parenteral for the Years 2014, 2024 & 2030
TABLE 38: USA Recent Past, Current & Future Analysis for Vitamin D Therapy by Application - Other Applications, Osteoporosis, Rickets, Muscle Weakness, Autoimmune Disorders and Skin Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 39: USA Historic Review for Vitamin D Therapy by Application - Other Applications, Osteoporosis, Rickets, Muscle Weakness, Autoimmune Disorders and Skin Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 40: USA 16-Year Perspective for Vitamin D Therapy by Application - Percentage Breakdown of Value Sales for Other Applications, Osteoporosis, Rickets, Muscle Weakness, Autoimmune Disorders and Skin Diseases for the Years 2014, 2024 & 2030
TABLE 41: USA Recent Past, Current & Future Analysis for Vitamin D Therapy by Method - Prescription Drugs and OTC Drugs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 42: USA Historic Review for Vitamin D Therapy by Method - Prescription Drugs and OTC Drugs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 43: USA 16-Year Perspective for Vitamin D Therapy by Method - Percentage Breakdown of Value Sales for Prescription Drugs and OTC Drugs for the Years 2014, 2024 & 2030
CANADA
TABLE 44: Canada Recent Past, Current & Future Analysis for Vitamin D Therapy by Route Of Administration - Oral and Parenteral - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 45: Canada Historic Review for Vitamin D Therapy by Route Of Administration - Oral and Parenteral Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 46: Canada 16-Year Perspective for Vitamin D Therapy by Route Of Administration - Percentage Breakdown of Value Sales for Oral and Parenteral for the Years 2014, 2024 & 2030
TABLE 47: Canada Recent Past, Current & Future Analysis for Vitamin D Therapy by Application - Other Applications, Osteoporosis, Rickets, Muscle Weakness, Autoimmune Disorders and Skin Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 48: Canada Historic Review for Vitamin D Therapy by Application - Other Applications, Osteoporosis, Rickets, Muscle Weakness, Autoimmune Disorders and Skin Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 49: Canada 16-Year Perspective for Vitamin D Therapy by Application - Percentage Breakdown of Value Sales for Other Applications, Osteoporosis, Rickets, Muscle Weakness, Autoimmune Disorders and Skin Diseases for the Years 2014, 2024 & 2030
TABLE 50: Canada Recent Past, Current & Future Analysis for Vitamin D Therapy by Method - Prescription Drugs and OTC Drugs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 51: Canada Historic Review for Vitamin D Therapy by Method - Prescription Drugs and OTC Drugs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 52: Canada 16-Year Perspective for Vitamin D Therapy by Method - Percentage Breakdown of Value Sales for Prescription Drugs and OTC Drugs for the Years 2014, 2024 & 2030
JAPAN
Vitamin D Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
TABLE 53: Japan Recent Past, Current & Future Analysis for Vitamin D Therapy by Route Of Administration - Oral and Parenteral - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 54: Japan Historic Review for Vitamin D Therapy by Route Of Administration - Oral and Parenteral Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 55: Japan 16-Year Perspective for Vitamin D Therapy by Route Of Administration - Percentage Breakdown of Value Sales for Oral and Parenteral for the Years 2014, 2024 & 2030
TABLE 56: Japan Recent Past, Current & Future Analysis for Vitamin D Therapy by Application - Other Applications, Osteoporosis, Rickets, Muscle Weakness, Autoimmune Disorders and Skin Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 57: Japan Historic Review for Vitamin D Therapy by Application - Other Applications, Osteoporosis, Rickets, Muscle Weakness, Autoimmune Disorders and Skin Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 58: Japan 16-Year Perspective for Vitamin D Therapy by Application - Percentage Breakdown of Value Sales for Other Applications, Osteoporosis, Rickets, Muscle Weakness, Autoimmune Disorders and Skin Diseases for the Years 2014, 2024 & 2030
TABLE 59: Japan Recent Past, Current & Future Analysis for Vitamin D Therapy by Method - Prescription Drugs and OTC Drugs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 60: Japan Historic Review for Vitamin D Therapy by Method - Prescription Drugs and OTC Drugs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 61: Japan 16-Year Perspective for Vitamin D Therapy by Method - Percentage Breakdown of Value Sales for Prescription Drugs and OTC Drugs for the Years 2014, 2024 & 2030
CHINA
Vitamin D Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
TABLE 62: China Recent Past, Current & Future Analysis for Vitamin D Therapy by Route Of Administration - Oral and Parenteral - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 63: China Historic Review for Vitamin D Therapy by Route Of Administration - Oral and Parenteral Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 64: China 16-Year Perspective for Vitamin D Therapy by Route Of Administration - Percentage Breakdown of Value Sales for Oral and Parenteral for the Years 2014, 2024 & 2030
TABLE 65: China Recent Past, Current & Future Analysis for Vitamin D Therapy by Application - Other Applications, Osteoporosis, Rickets, Muscle Weakness, Autoimmune Disorders and Skin Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 66: China Historic Review for Vitamin D Therapy by Application - Other Applications, Osteoporosis, Rickets, Muscle Weakness, Autoimmune Disorders and Skin Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 67: China 16-Year Perspective for Vitamin D Therapy by Application - Percentage Breakdown of Value Sales for Other Applications, Osteoporosis, Rickets, Muscle Weakness, Autoimmune Disorders and Skin Diseases for the Years 2014, 2024 & 2030
TABLE 68: China Recent Past, Current & Future Analysis for Vitamin D Therapy by Method - Prescription Drugs and OTC Drugs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 69: China Historic Review for Vitamin D Therapy by Method - Prescription Drugs and OTC Drugs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 70: China 16-Year Perspective for Vitamin D Therapy by Method - Percentage Breakdown of Value Sales for Prescription Drugs and OTC Drugs for the Years 2014, 2024 & 2030
EUROPE
Vitamin D Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
TABLE 71: Europe Recent Past, Current & Future Analysis for Vitamin D Therapy by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 72: Europe Historic Review for Vitamin D Therapy by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 73: Europe 16-Year Perspective for Vitamin D Therapy by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
TABLE 74: Europe Recent Past, Current & Future Analysis for Vitamin D Therapy by Route Of Administration - Oral and Parenteral - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 75: Europe Historic Review for Vitamin D Therapy by Route Of Administration - Oral and Parenteral Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 76: Europe 16-Year Perspective for Vitamin D Therapy by Route Of Administration - Percentage Breakdown of Value Sales for Oral and Parenteral for the Years 2014, 2024 & 2030
TABLE 77: Europe Recent Past, Current & Future Analysis for Vitamin D Therapy by Application - Other Applications, Osteoporosis, Rickets, Muscle Weakness, Autoimmune Disorders and Skin Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 78: Europe Historic Review for Vitamin D Therapy by Application - Other Applications, Osteoporosis, Rickets, Muscle Weakness, Autoimmune Disorders and Skin Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 79: Europe 16-Year Perspective for Vitamin D Therapy by Application - Percentage Breakdown of Value Sales for Other Applications, Osteoporosis, Rickets, Muscle Weakness, Autoimmune Disorders and Skin Diseases for the Years 2014, 2024 & 2030
TABLE 80: Europe Recent Past, Current & Future Analysis for Vitamin D Therapy by Method - Prescription Drugs and OTC Drugs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 81: Europe Historic Review for Vitamin D Therapy by Method - Prescription Drugs and OTC Drugs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 82: Europe 16-Year Perspective for Vitamin D Therapy by Method - Percentage Breakdown of Value Sales for Prescription Drugs and OTC Drugs for the Years 2014, 2024 & 2030
FRANCE
Vitamin D Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
TABLE 83: France Recent Past, Current & Future Analysis for Vitamin D Therapy by Route Of Administration - Oral and Parenteral - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 84: France Historic Review for Vitamin D Therapy by Route Of Administration - Oral and Parenteral Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 85: France 16-Year Perspective for Vitamin D Therapy by Route Of Administration - Percentage Breakdown of Value Sales for Oral and Parenteral for the Years 2014, 2024 & 2030
TABLE 86: France Recent Past, Current & Future Analysis for Vitamin D Therapy by Application - Other Applications, Osteoporosis, Rickets, Muscle Weakness, Autoimmune Disorders and Skin Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 87: France Historic Review for Vitamin D Therapy by Application - Other Applications, Osteoporosis, Rickets, Muscle Weakness, Autoimmune Disorders and Skin Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 88: France 16-Year Perspective for Vitamin D Therapy by Application - Percentage Breakdown of Value Sales for Other Applications, Osteoporosis, Rickets, Muscle Weakness, Autoimmune Disorders and Skin Diseases for the Years 2014, 2024 & 2030
TABLE 89: France Recent Past, Current & Future Analysis for Vitamin D Therapy by Method - Prescription Drugs and OTC Drugs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 90: France Historic Review for Vitamin D Therapy by Method - Prescription Drugs and OTC Drugs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 91: France 16-Year Perspective for Vitamin D Therapy by Method - Percentage Breakdown of Value Sales for Prescription Drugs and OTC Drugs for the Years 2014, 2024 & 2030
GERMANY
Vitamin D Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
TABLE 92: Germany Recent Past, Current & Future Analysis for Vitamin D Therapy by Route Of Administration - Oral and Parenteral - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 93: Germany Historic Review for Vitamin D Therapy by Route Of Administration - Oral and Parenteral Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 94: Germany 16-Year Perspective for Vitamin D Therapy by Route Of Administration - Percentage Breakdown of Value Sales for Oral and Parenteral for the Years 2014, 2024 & 2030
TABLE 95: Germany Recent Past, Current & Future Analysis for Vitamin D Therapy by Application - Other Applications, Osteoporosis, Rickets, Muscle Weakness, Autoimmune Disorders and Skin Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 96: Germany Historic Review for Vitamin D Therapy by Application - Other Applications, Osteoporosis, Rickets, Muscle Weakness, Autoimmune Disorders and Skin Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 97: Germany 16-Year Perspective for Vitamin D Therapy by Application - Percentage Breakdown of Value Sales for Other Applications, Osteoporosis, Rickets, Muscle Weakness, Autoimmune Disorders and Skin Diseases for the Years 2014, 2024 & 2030
TABLE 98: Germany Recent Past, Current & Future Analysis for Vitamin D Therapy by Method - Prescription Drugs and OTC Drugs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 99: Germany Historic Review for Vitamin D Therapy by Method - Prescription Drugs and OTC Drugs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 100: Germany 16-Year Perspective for Vitamin D Therapy by Method - Percentage Breakdown of Value Sales for Prescription Drugs and OTC Drugs for the Years 2014, 2024 & 2030
ITALY
TABLE 101: Italy Recent Past, Current & Future Analysis for Vitamin D Therapy by Route Of Administration - Oral and Parenteral - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 102: Italy Historic Review for Vitamin D Therapy by Route Of Administration - Oral and Parenteral Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 103: Italy 16-Year Perspective for Vitamin D Therapy by Route Of Administration - Percentage Breakdown of Value Sales for Oral and Parenteral for the Years 2014, 2024 & 2030
TABLE 104: Italy Recent Past, Current & Future Analysis for Vitamin D Therapy by Application - Other Applications, Osteoporosis, Rickets, Muscle Weakness, Autoimmune Disorders and Skin Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 105: Italy Historic Review for Vitamin D Therapy by Application - Other Applications, Osteoporosis, Rickets, Muscle Weakness, Autoimmune Disorders and Skin Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 106: Italy 16-Year Perspective for Vitamin D Therapy by Application - Percentage Breakdown of Value Sales for Other Applications, Osteoporosis, Rickets, Muscle Weakness, Autoimmune Disorders and Skin Diseases for the Years 2014, 2024 & 2030
TABLE 107: Italy Recent Past, Current & Future Analysis for Vitamin D Therapy by Method - Prescription Drugs and OTC Drugs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 108: Italy Historic Review for Vitamin D Therapy by Method - Prescription Drugs and OTC Drugs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 109: Italy 16-Year Perspective for Vitamin D Therapy by Method - Percentage Breakdown of Value Sales for Prescription Drugs and OTC Drugs for the Years 2014, 2024 & 2030
UNITED KINGDOM
Vitamin D Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
TABLE 110: UK Recent Past, Current & Future Analysis for Vitamin D Therapy by Route Of Administration - Oral and Parenteral - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 111: UK Historic Review for Vitamin D Therapy by Route Of Administration - Oral and Parenteral Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 112: UK 16-Year Perspective for Vitamin D Therapy by Route Of Administration - Percentage Breakdown of Value Sales for Oral and Parenteral for the Years 2014, 2024 & 2030
TABLE 113: UK Recent Past, Current & Future Analysis for Vitamin D Therapy by Application - Other Applications, Osteoporosis, Rickets, Muscle Weakness, Autoimmune Disorders and Skin Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 114: UK Historic Review for Vitamin D Therapy by Application - Other Applications, Osteoporosis, Rickets, Muscle Weakness, Autoimmune Disorders and Skin Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 115: UK 16-Year Perspective for Vitamin D Therapy by Application - Percentage Breakdown of Value Sales for Other Applications, Osteoporosis, Rickets, Muscle Weakness, Autoimmune Disorders and Skin Diseases for the Years 2014, 2024 & 2030
TABLE 116: UK Recent Past, Current & Future Analysis for Vitamin D Therapy by Method - Prescription Drugs and OTC Drugs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 117: UK Historic Review for Vitamin D Therapy by Method - Prescription Drugs and OTC Drugs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 118: UK 16-Year Perspective for Vitamin D Therapy by Method - Percentage Breakdown of Value Sales for Prescription Drugs and OTC Drugs for the Years 2014, 2024 & 2030
REST OF EUROPE
TABLE 119: Rest of Europe Recent Past, Current & Future Analysis for Vitamin D Therapy by Route Of Administration - Oral and Parenteral - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 120: Rest of Europe Historic Review for Vitamin D Therapy by Route Of Administration - Oral and Parenteral Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 121: Rest of Europe 16-Year Perspective for Vitamin D Therapy by Route Of Administration - Percentage Breakdown of Value Sales for Oral and Parenteral for the Years 2014, 2024 & 2030
TABLE 122: Rest of Europe Recent Past, Current & Future Analysis for Vitamin D Therapy by Application - Other Applications, Osteoporosis, Rickets, Muscle Weakness, Autoimmune Disorders and Skin Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 123: Rest of Europe Historic Review for Vitamin D Therapy by Application - Other Applications, Osteoporosis, Rickets, Muscle Weakness, Autoimmune Disorders and Skin Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 124: Rest of Europe 16-Year Perspective for Vitamin D Therapy by Application - Percentage Breakdown of Value Sales for Other Applications, Osteoporosis, Rickets, Muscle Weakness, Autoimmune Disorders and Skin Diseases for the Years 2014, 2024 & 2030
TABLE 125: Rest of Europe Recent Past, Current & Future Analysis for Vitamin D Therapy by Method - Prescription Drugs and OTC Drugs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 126: Rest of Europe Historic Review for Vitamin D Therapy by Method - Prescription Drugs and OTC Drugs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 127: Rest of Europe 16-Year Perspective for Vitamin D Therapy by Method - Percentage Breakdown of Value Sales for Prescription Drugs and OTC Drugs for the Years 2014, 2024 & 2030
ASIA-PACIFIC
Vitamin D Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
TABLE 128: Asia-Pacific Recent Past, Current & Future Analysis for Vitamin D Therapy by Route Of Administration - Oral and Parenteral - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 129: Asia-Pacific Historic Review for Vitamin D Therapy by Route Of Administration - Oral and Parenteral Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 130: Asia-Pacific 16-Year Perspective for Vitamin D Therapy by Route Of Administration - Percentage Breakdown of Value Sales for Oral and Parenteral for the Years 2014, 2024 & 2030
TABLE 131: Asia-Pacific Recent Past, Current & Future Analysis for Vitamin D Therapy by Application - Other Applications, Osteoporosis, Rickets, Muscle Weakness, Autoimmune Disorders and Skin Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 132: Asia-Pacific Historic Review for Vitamin D Therapy by Application - Other Applications, Osteoporosis, Rickets, Muscle Weakness, Autoimmune Disorders and Skin Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 133: Asia-Pacific 16-Year Perspective for Vitamin D Therapy by Application - Percentage Breakdown of Value Sales for Other Applications, Osteoporosis, Rickets, Muscle Weakness, Autoimmune Disorders and Skin Diseases for the Years 2014, 2024 & 2030
TABLE 134: Asia-Pacific Recent Past, Current & Future Analysis for Vitamin D Therapy by Method - Prescription Drugs and OTC Drugs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 135: Asia-Pacific Historic Review for Vitamin D Therapy by Method - Prescription Drugs and OTC Drugs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 136: Asia-Pacific 16-Year Perspective for Vitamin D Therapy by Method - Percentage Breakdown of Value Sales for Prescription Drugs and OTC Drugs for the Years 2014, 2024 & 2030
REST OF WORLD
TABLE 137: Rest of World Recent Past, Current & Future Analysis for Vitamin D Therapy by Route Of Administration - Oral and Parenteral - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 138: Rest of World Historic Review for Vitamin D Therapy by Route Of Administration - Oral and Parenteral Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 139: Rest of World 16-Year Perspective for Vitamin D Therapy by Route Of Administration - Percentage Breakdown of Value Sales for Oral and Parenteral for the Years 2014, 2024 & 2030
TABLE 140: Rest of World Recent Past, Current & Future Analysis for Vitamin D Therapy by Application - Other Applications, Osteoporosis, Rickets, Muscle Weakness, Autoimmune Disorders and Skin Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 141: Rest of World Historic Review for Vitamin D Therapy by Application - Other Applications, Osteoporosis, Rickets, Muscle Weakness, Autoimmune Disorders and Skin Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 142: Rest of World 16-Year Perspective for Vitamin D Therapy by Application - Percentage Breakdown of Value Sales for Other Applications, Osteoporosis, Rickets, Muscle Weakness, Autoimmune Disorders and Skin Diseases for the Years 2014, 2024 & 2030
TABLE 143: Rest of World Recent Past, Current & Future Analysis for Vitamin D Therapy by Method - Prescription Drugs and OTC Drugs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 144: Rest of World Historic Review for Vitamin D Therapy by Method - Prescription Drugs and OTC Drugs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 145: Rest of World 16-Year Perspective for Vitamin D Therapy by Method - Percentage Breakdown of Value Sales for Prescription Drugs and OTC Drugs for the Years 2014, 2024 & 2030
